4.5 Article

Oxycodone findings and CYP2D6 function in postmortem cases

Journal

FORENSIC SCIENCE INTERNATIONAL-GENETICS
Volume 53, Issue -, Pages -

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.fsigen.2021.102510

Keywords

Oxycodone related deaths; Pharmacogenetics; Postmortem toxicology; Metabolite ratios; Forensic Toxicology

Funding

  1. Strategic Research Area of Forensic Science at Linkoping University, Sweden [2017-8]
  2. National Board of Forensic Medicine in Sweden

Ask authors/readers for more resources

This study investigates the impact of CYP2D6 phenotype on oxycodone concentrations in postmortem cases, finding that poor and intermediate metabolizers have higher concentrations compared to extensive and ultra-rapid metabolizers. The distribution of CYP2D6 phenotypes was similar among different causes of death, indicating no overrepresentation of a particular phenotype in any cause of death group. Additionally, the ratio of oxymorphone to oxycodone is dependent on CYP2D6 activity, with a lower ratio indicating acute intake and potentially serving as a sensitive marker for distinguishing oxycodone intoxications from other causes of death.
Genetic disposition can cause variation in oxycodone pharmacokinetic characteristics and decrease or increase the expected clinical response. In forensic medicine, determination of cause of death or assessing time between drug intake and death can be facilitated by knowledge of parent and metabolite concentrations. In this study, the aim was to investigate if CYP2D6 genotyping can facilitate interpretation by investigating the frequency of the four CYP2D6 phenotypes, poor metabolizer, intermediate metabolizer, extensive metabolizer, and ultra-rapid metabolizer in postmortem cases, and to study if the CYP2D6 activity was associated with a certain cause of death, concentration, or metabolic ratio. Cases positive for oxycodone in femoral blood (n = 174) were genotyped by pyrosequencing for CYP2D6*3, *4, and *6 and concentrations of oxycodone, noroxycodone, oxymorphone, and noroxymorphone were determined by LC-MS/MS (LLOQ 0.005 mu g/g). Digital droplet PCR was used to determine the copy number variation for CYP2D6*5. Cases were categorized by cause of death. It was found that poor and intermediate CYP2D6 metabolizers had significantly higher oxycodone and noroxycodone concentrations compared to extensive and ultra-rapid metabolizers. CYP2D6 phenotype were equally distributed between cause of death groups, showing that no phenotype was overrepresented in any of the cause of death groups. We also found that the concentration ratio between oxymorphone and oxycodone depended on the CYP2D6 activity when death was unrelated to intoxication. In general, a low metabolite to parent ratio indicate an acute intake. By using receiver operating characteristic (ROC) analysis, we conclude that an oxymorphone/ oxycodone ratio lower than 0.075 has a high sensitivity for separating intoxications with oxycodone from other intoxications and non-intoxications. However, the phenotype needs to be known to reach a high specificity. Therefore, the ratio should not be used as a biomarker on its own to distinguish between different causes of death but needs to be complemented by genotyping.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available